HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Joshua D Safer Selected Research

Sex Reassignment Surgery

1/2021No Venous Thromboembolism Increase Among Transgender Female Patients Remaining on Estrogen for Gender-Affirming Surgery.
1/2021Response to Letter to the Editor from Blasdel et al: "No Venous Thromboembolism Increase Among Transgender Female Patients Remaining on Estrogen for Gender Affirming Surgery".
11/2020Endocrine treatment of transgender individuals: current guidelines and strategies.
1/2020HIGH BODY MASS INDEX IS A SIGNIFICANT BARRIER TO GENDER-CONFIRMATION SURGERY FOR TRANSGENDER AND GENDER-NONBINARY INDIVIDUALS.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Joshua D Safer Research Topics

Disease

4Neoplasms (Cancer)
04/2022 - 04/2016
4Venous Thromboembolism
06/2021 - 01/2019
3Thyroid Diseases (Thyroid Disease)
01/2013 - 09/2008
2Gender Dysphoria
12/2017 - 11/2017
2Skin Manifestations
01/2013 - 10/2012
2Wounds and Injuries (Trauma)
01/2012 - 10/2005
1Heart Diseases (Heart Disease)
01/2021
1Hyperlipidemias (Hyperlipidemia)
11/2020
1Virilism (Virilization)
11/2020
1Atrophy
11/2020
1Uterine Cervical Neoplasms (Cancer of the Cervix)
03/2020
1Breast Neoplasms (Breast Cancer)
01/2020
1Genetic Predisposition to Disease (Genetic Predisposition)
01/2020
1Obesity
01/2020
1Osteoporosis
10/2019
1Hyperparathyroidism
10/2019
1Hyperprolactinemia
07/2018
1Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
06/2018
1Dyslipidemias (Dyslipidemia)
06/2018
1Menstruation Disturbances
06/2018
1Disorders of Sex Development (Intersexuality)
02/2015
1Thyrotoxicosis
11/2011
1Myxedema
07/2011
1Hyperthyroidism
07/2010
1Weight Gain
07/2010
1Confusion (Bewilderment)
09/2008
1Hypothyroidism
09/2008
1Growth Disorders
03/2007

Drug/Important Bio-Agent (IBA)

10Hormones (Hormone)IBA
04/2022 - 04/2016
5Thyroid HormonesIBA
01/2013 - 10/2005
4Estrogens (Estrogen)FDA Link
01/2021 - 01/2019
4AndrogensIBA
11/2020 - 01/2012
2Spironolactone (Aldactone)FDA LinkGeneric
11/2020 - 07/2018
2Testosterone (Sustanon)FDA Link
11/2020 - 06/2018
2Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
07/2010 - 09/2008
2Triiodothyronine (Liothyronine)FDA LinkGeneric
07/2010 - 09/2008
1Biomarkers (Surrogate Marker)IBA
04/2022
1ProlactinIBA
11/2020
1Androgen Antagonists (Antiandrogens)IBA
11/2020
1DNA (Deoxyribonucleic Acid)IBA
03/2020
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
01/2020
1Aromatase InhibitorsIBA
01/2020
1TamoxifenFDA LinkGeneric
01/2020
1SteroidsIBA
10/2019
1Estradiol (Delestrogen)FDA LinkGeneric
07/2018
1oxidized low density lipoproteinIBA
06/2018
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
06/2018
1LDL Lipoproteins (beta Lipoproteins)IBA
06/2018
1HDL LipoproteinsIBA
06/2018
1Biological ProductsIBA
02/2015
1GlycosaminoglycansIBA
07/2011
1AutoantibodiesIBA
09/2008
1AntibodiesIBA
09/2008
1Thyroxine (Levothyroxine)FDA LinkGeneric
09/2008
1Peptides (Polypeptides)IBA
03/2007

Therapy/Procedure

5Therapeutics
06/2021 - 07/2010
4Sex Reassignment Surgery
01/2021 - 01/2020
1Orchiectomy (Orchidectomy)
11/2020
1Contraindications
01/2020
1Segmental Mastectomy (Lumpectomy)
01/2020
1Aftercare (After-Treatment)
07/2010